Chronic central leptin infusion restores cardiac sympathetic-vagal balance and baroreflex sensitivity in diabetic rats
- 1 November 2008
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 295 (5) , H1974-H1981
Abstract
This study tested whether leptin restores sympathetic-vagal balance, heart rate (HR) variability, and cardiac baroreflex sensitivity (BRS) in streptozotocin (STZ)-induced diabetes. Sprague-Dawley rats were instrumented with arterial and venous catheters, and a cannula was placed in the lateral ventricle for intracerebroventricular (ICV) leptin infusion. Blood pressure (BP) and HR were monitored by telemetry. BRS and HR variability were estimated by linear regression between HR and BP responses to phenylephrine or sodium nitroprusside and autoregressive spectral analysis. Measurements were made during control period, 7 days after induction of diabetes, and 7 days after ICV leptin infusion. STZ diabetes was associated with hyperglycemia (422 ± 17 mg/dl) and bradycardia (−79 ± 4 beats/min). Leptin decreased glucose levels (165 ± 16 mg/dl) and raised HR to control values (303 ± 10 to 389 ± 10 beats/min). Intrinsic HR (IHR) and chronotropic responses to a full-blocking dose of propranolol and atropine were reduced during diabetes (260 ± 7 vs. 316 ± 6, −19 ± 2 vs. −43 ± 6, and 39 ± 3 vs. 68 ± 8 beats/min), and leptin treatment restored these variables to normal (300 ± 7, −68 ± 10, and 71 ± 8 beats/min). Leptin normalized BRS (bradycardia, −2.6 ± 0.3, −1.7 ± 0.2, and −3.0 ± 0.5; and tachycardia, −3.2 ± 0.4, −1.9 ± 0.3, and −3.4 ± 0.3 beats·min−1·mmHg−1 for control, diabetes, and leptin) and HR variability (23 ± 4 to 11 ± 1.5 ms2). Chronic glucose infusion to maintain hyperglycemia during leptin infusion did not alter the effect of leptin on IHR but abolished the improved BRS. These results show rapid impairment of autonomic nervous system control of HR after the induction of diabetes and that central nervous system actions of leptin can abolish the hyperglycemia as well as the altered IHR and BRS in STZ-induced diabetes.Keywords
This publication has 43 references indexed in Scilit:
- Type 1 Diabetes Associated with Acquired Generalized Lipodystrophy and Insulin Resistance: The Effect of Long-Term Leptin TherapyThe Journal of Clinical Endocrinology & Metabolism, 2008
- Chronic antidiabetic and cardiovascular actions of leptin: role of CNS and increased adrenergic activityAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2006
- Melanocortin-4 Receptor Mediates Chronic Cardiovascular and Metabolic Actions of LeptinHypertension, 2006
- Role of Hypothalamic Melanocortin 3/4-Receptors in Mediating Chronic Cardiovascular, Renal, and Metabolic Actions of LeptinHypertension, 2004
- Reflex control of arterial pressure and heart rate in short-term streptozotocin diabetic ratsBrazilian Journal of Medical and Biological Research, 2002
- Leptin-Replacement Therapy for LipodystrophyNew England Journal of Medicine, 2002
- Chronic Cardiovascular and Renal Actions of LeptinHypertension, 2002
- Heart Rate Variability and Baroreceptor Function in Chronic Diabetic RatsHypertension, 1997
- Autonomic Dysfunction in Short-term Experimental DiabetesHypertension, 1995
- Effect of a β3-adrenergic agonist, BRL35135A, on glucose uptake in rat skeletal muscle in vivo and in vitroJournal of Endocrinology, 1993